Medscape To Develop FDA Biosimilars Educational Program
Courses Will Be Created To Enhance HCPs’ Understanding Of Biosimilars
Executive Summary
Medscape Education has been awarded an FDA contract to develop an educational program about biosimilars for US healthcare professionals, which is set to launch in spring this year.
You may also be interested in...
US FDA Plans Education Efforts As Humira Biosimilars Launch
Just-in-time education may be preferred, so patients and providers see it as they are making decisions, OTBB Director Sarah Yim says in an interview.
Cutting Through The Confusion On US Biosimilar Interchangeability
Amid ongoing confusion around the US interchangeability designation for biosimilars, Joseph Park and Gillian Woollett of Samsung Bioepis talk about the risks of misinformation, the importance of educational efforts, and how language is shaping certain misunderstandings.
Cutting Through The Confusion On US Biosimilar Interchangeability
Amid ongoing confusion around the US interchangeability designation for biosimilars, Joseph Park and Gillian Woollett of Samsung Bioepis talk to Generics Bulletin about the risks of misinformation, the importance of educational efforts, and how language is shaping certain misunderstandings around biosimilars.